Stifel analyst Craig Jones raised the firm’s price target on Alignment Healthcare to $12 from $9 and keeps a Buy rating on the shares ahead of Alignment reporting Q2 earnings on Thursday, August 1. The firm expects Alignment to beat on revenue and increase the annual guidance with members coming in above the high end of the range, the analyst tells investors in a preview.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare to Announce Second Quarter 2024 Financial Results and Host Conference Call Thursday, Aug. 1, 2024
- Alignment Healthcare announces improvement of NC, NV MA HMO 2024 rating
- Alignment Healthcare upgraded to Buy from Neutral at BofA
- Alignment Healthcare initiated with an Outperform at Baird